4//SEC Filing
Rodman David Malcom 4
Accession 0001672659-26-000008
CIK 0001933414other
Filed
Jan 19, 7:00 PM ET
Accepted
Jan 20, 8:33 PM ET
Size
8.4 KB
Accession
0001672659-26-000008
Insider Transaction Report
Form 4
Rodman David Malcom
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
[F1]2026-01-20$15.44/sh+416$6,423→ 50,853 total - Sale
Common Stock
[F1]2026-01-20$32.10/sh−416$13,354→ 50,437 total - Exercise/Conversion
Stock Option
[F1][F2]2026-01-20−416→ 5,834 totalExercise: $15.44Exp: 2033-03-17→ Common Stock (416 underlying)
Footnotes (2)
- [F1]These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025.
- [F2]The stock option vested as to 25% of the underlying shares on the first anniversary of the grant date, with the remaining shares vesting in 36 substantially equal monthly installments thereafter.
Signature
/s/ Adam Levy, Attorney-in-fact|2026-01-20
Documents
Issuer
Mineralys Therapeutics, Inc.
CIK 0001933414
Entity typeother
Related Parties
1- filerCIK 0001672659
Filing Metadata
- Form type
- 4
- Filed
- Jan 19, 7:00 PM ET
- Accepted
- Jan 20, 8:33 PM ET
- Size
- 8.4 KB